Related Experiment Video
Updated: Oct 9, 2025

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in
Senxu Lu1,2, Xiangyu Ding1,2, Yuanhe Wang3
1Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
Abstract:
Recent accumulating researches implicate that non-coding RNAs (ncRNAs) including microRNA (miRNA), circular RNA (circRNA), and long non-coding RNA (lncRNAs) play crucial roles in colorectal cancer (CRC) initiation and development. Notably, N6-methyladenosine (m6A) methylation, the critical posttranscriptional modulators, exerts various functions in ncRNA metabolism such as stability and degradation. However, the interaction regulation network among ncRNAs and the interplay with m6A-related regulators has not been well documented, particularly in CRC. Here, we summarize the interaction networks and sub-networks of ncRNAs in CRC based on a data-driven approach from the publications (IF > 6) in the last quinquennium (2016-2021). Further, we extend the regulatory pattern between the core m6A regulators and m6A-related ncRNAs in the context of CRC metastasis and progression. Thus, our review will highlight the clinical potential of ncRNAs and m6A modifiers as promising biomarkers and therapeutic targets for improving the diagnostic precision and treatment of CRC.
Insights
Non-coding RNAs (ncRNAs) and N6-methyladenosine (m6A) methylation are key in colorectal cancer (CRC). This review details their interactions, offering potential for improved CRC diagnostics and therapeutics.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs), are increasingly recognized for their roles in colorectal cancer (CRC) pathogenesis.
- N6-methyladenosine (m6A) methylation, a crucial epitranscriptomic modification, significantly influences ncRNA metabolism, affecting their stability and degradation pathways.
- The intricate regulatory networks between ncRNAs and m6A modifications in the context of CRC remain incompletely understood.
Purpose of the Study:
- To systematically review and summarize the interaction networks of ncRNAs in colorectal cancer.
- To elucidate the interplay between m6A regulators and ncRNAs in CRC progression and metastasis.
- To highlight the translational potential of ncRNAs and m6A modifiers as biomarkers and therapeutic targets for CRC.
Main Methods:
- A data-driven approach was employed, analyzing publications with an impact factor greater than 6 from 2016 to 2021.
- Literature review focused on identifying and characterizing ncRNA interaction networks and sub-networks within CRC.
- The review extended to analyze the regulatory patterns involving core m6A regulators and their associated ncRNAs in CRC metastasis and progression.
Main Results:
- Accumulated research implicates diverse ncRNAs in the initiation and development of colorectal cancer.
- m6A methylation critically modulates ncRNA metabolism, impacting their functional roles in cancer.
- Established interaction networks and regulatory patterns between ncRNAs and m6A machinery provide a framework for understanding CRC biology.
Conclusions:
- ncRNA-ncRNA and ncRNA-m6A interactions form complex regulatory networks crucial for colorectal cancer development.
- Understanding these networks offers insights into CRC metastasis and progression mechanisms.
- ncRNAs and m6A modifiers represent promising avenues for developing novel diagnostic biomarkers and therapeutic strategies for colorectal cancer.
Related Concept Videos
MicroRNAs
RNA Stability
lncRNA - Long Non-coding RNAs
RNA Editing
Nuclear Export of mRNA
Epigenetic Regulation
X-chromosome...

